Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-18

Clinical Trial Update: Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a specialized cocktail to reduce edema in ultra-early management of ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • specialized edema-reducing cocktail

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING